Investing in healthcare for positive impact, with Chris Welsford
ESG or impact fund managers often hold healthcare stocks because they align with the United Nations’ third Sustainable Development Goal: to ‘ensure healthy lives and promote well-being for all at all ages’.
However, many larger healthcare companies have controversies to their name, ranging from charges of bribery to poor care. There is also a question about their role in the privatisation of healthcare in countries such as the UK which have a public health service.
Chris Welsford, managing director of Ayres Punchard Investment Management, discusses a well-known example: Centene, a £67.2bn US health insurer. We discuss the company’s controversies, our engagement with sustainable funds holding Centene, and investing for positive impact.
ESG or impact fund managers often hold healthcare stocks because they align with the United Nations’ third Sustainable Development Goal: to ‘ensure healthy lives and promote well-being for all at all ages’.
However, many larger healthcare companies have controversies to their name, ranging from charges of bribery to poor care. There is also a question about their role in the privatisation of healthcare in countries such as the UK which have a public health service.
Chris Welsford, managing director of Ayres Punchard Investment Management, discusses a well-known example: Centene, a £67.2bn US health insurer. We discuss the company’s controversies, our engagement with sustainable funds holding Centene, and investing for positive impact.
